Barinthus Biotherapeutics Plc Share Price (NASDAQ: BRNS)
$1.12
Last updated on
Check the interactive Barinthus Biotherapeutics Plc Stock chart to analyse performance
Barinthus Biotherapeutics Plc stock performance
as on August 30, 2025 at 1:25 am IST
- Today's Low:$1.12Today's High:$1.14
0.0%
Downside
Day's Volatility :1.75%
Upside
1.75%
- 52 Weeks Low:$0.6452 Weeks High:$2.92
42.86%
Downside
52 Weeks Volatility :78.08%
Upside
61.64%
Barinthus Biotherapeutics Plc Stock Returns
Barinthus Biotherapeutics Plc Key Stats
Check Barinthus Biotherapeutics Plc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Barinthus Biotherapeutics Plc Stock including INR - Dollar returns
The Barinthus Biotherapeutics Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Barinthus Biotherapeutics Plc investment value today
Current value as on today
₹90,133
Returns
Returns from Barinthus Biotherapeutics Plc Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Barinthus Biotherapeutics Plc Stock
Global Institutional Holdings in Barinthus Biotherapeutics Plc
Name
Holdings %
M&G PLC
12.88%
Alphabet Inc
3.75%
SC China Holding Ltd
3.52%
DC Funds, LP
1.59%
Baird Financial Group, Inc.
0.48%
The Johns Hopkins University
0.30%
Analyst Recommendation on Barinthus Biotherapeutics Plc Stock
Buy
83%Buy
16%Hold
0%Sell
Based on 12 Wall street analysts offering stock ratings for Barinthus Biotherapeutics Plc(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Barinthus Biotherapeutics Plc Share Price Target
What analysts predicted
Upside of 301.79%
Target:
$4.50
Current:
$1.12
Barinthus Biotherapeutics Plc share price target is $4.50, a slight Upside of 301.79% compared to current price of $1.12 as per analysts' prediction.
Barinthus Biotherapeutics Plc Stock Insights
Price Movement
In the last 1 month, BRNS stock has moved down by -20.8%Decreasing Revenue
Revenue is down for the last 2 quarters, 14.96M → -9.17M (in $), with an average decrease of 161.3% per quarterDecreasing Net Profit
Netprofit is down for the last 2 quarters, -19.64M → -21.12M (in $), with an average decrease of 7.5% per quarterBRNS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 83.2%BRNS vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 187.3%Price to Sales
ForBRNS every $1 of sales, investors are willing to pay $3.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Barinthus Biotherapeutics Plc Technicals Summary
Sell
Neutral
Buy
Barinthus Biotherapeutics Plc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Barinthus Biotherapeutics Plc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -18.57% | 17.53% | -13.31% | -71.5% | -92.32% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
| 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -1.64 | -0.54 | -0.21 | NA | 2.54 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $48.0M | -92.32% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Barinthus Biotherapeutics Plc
Key Management of Barinthus Biotherapeutics Plc
Important FAQs about investing in BRNS Stock from India :
What is Barinthus Biotherapeutics Plc share price today?
Barinthus Biotherapeutics Plc share price today is $1.12 as on at the close of the market. Barinthus Biotherapeutics Plc share today touched a day high of $1.14 and a low of $1.12.
What is the 52 week high and 52 week low for Barinthus Biotherapeutics Plc share?
Barinthus Biotherapeutics Plc share touched a 52 week high of $2.92 and a 52 week low of $0.64. Barinthus Biotherapeutics Plc stock price today i.e. is closed at $1.12, lower by 61.64% versus the 52 week high.
How to invest in Barinthus Biotherapeutics Plc Stock (BRNS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Barinthus Biotherapeutics Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Barinthus Biotherapeutics Plc Shares that will get you 1.3393 shares as per Barinthus Biotherapeutics Plc share price of $1.12 per share as on August 30, 2025 at 1:25 am IST.
What is the minimum amount required to buy Barinthus Biotherapeutics Plc Stock (BRNS) from India?
Indian investors can start investing in Barinthus Biotherapeutics Plc (BRNS) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Barinthus Biotherapeutics Plc stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Barinthus Biotherapeutics Plc share’s latest price of $1.12 as on August 30, 2025 at 1:25 am IST, you will get 8.9286 shares of Barinthus Biotherapeutics Plc. Learn more about
fractional shares .
What are the returns that Barinthus Biotherapeutics Plc has given to Indian investors in the last 5 years?
Barinthus Biotherapeutics Plc stock has given -92.32% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
- Cambria Value And Momentum Etf
$32.55
+0.25%